Jason Raleigh Nunn, Director at Hyperion Therapeutics, holds 0.00 shares in Hyperion Therapeutics (Ticker: HPTX), holds ― shares in Regulus (Ticker: RGLS), holds 6.00K shares in Journey Medical Corp (Ticker: DERM).
Jason Raleigh Nunn latest transaction was an Uninformative Sell of $123.60K.
What was Jason Raleigh Nunn's most profitable transaction?
Jason Raleigh Nunn’s most profitable transaction was an Informative Buy of ZBIO stock on September 16, 2024. The return on the trade was 16.80%.
What is Jason Raleigh Nunn's role in Hyperion Therapeutics?
Jason Raleigh Nunn's role in Hyperion Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.